Ritse Mann, theme Women's cancers, receives up to 800,000 euros to develop an innovative research theme and to build up his own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.
We congratulate Ritse with this funding and wish him a lot of success with his great work.
Breast CT to improve clinical care for women with (suspected) breast cancer
Contrast-enhanced breast CT is a novel high resolution and fully 3D imaging method to document abnormalities within the breast. I will establish its value in the work-up of patients presenting with calcifications, in staging breast cancers, and in monitoring
therapy in a multi-center setting.
Ritse Mann, from the department Radiology and Nuclear Medicine, is a member within the theme Women's cancers.
Related news items
Exercise prevents new cardiovascular diseases4 March 2021
Exercise lowers the risk of glucose intolerance, obesity, elevated cholesterol and hypertension. The risk of new cardiovascular diseases can be lowered by an individual exercise guideline, argues epidemiologist Esmée Bakker in her dissertation on March 4.read more
Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism4 March 2021
Niels Riksen and colleagues identified increased inflammatory activity in patients with primary aldosteronism.read more
RIHS Awards ceremony Six winners4 March 2021
On 2 March, the RIHS Awards 2020 ceremony took place online. In front of an audience of more than 150 colleagues, RIHS awardees accepted their awards. New this year was the Patient Involvement Award for those who actively involved patients in their studies. Curious who they are? Read it now!read more